What's the best approach to managing a patient with type 2 diabetes, including medication and monitoring, for a SOAP note?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SOAP Note Approach for Type 2 Diabetes Management

Subjective

Start metformin at or near diagnosis along with lifestyle modifications unless contraindicated. 1, 2

Document the following key elements:

  • Glycemic symptoms: Polyuria, polydipsia, polyphagia, unexplained weight loss, blurred vision, fatigue 1
  • Hypoglycemia history: Frequency, severity, awareness status, episodes requiring assistance 1
  • Medication adherence: Current doses, timing, missed doses, side effects (especially GI symptoms with metformin) 3
  • Diet and exercise patterns: Minutes of physical activity per week, dietary composition, meal timing 1
  • Cardiovascular symptoms: Chest pain, dyspnea, claudication, prior MI or stroke 4
  • Microvascular complications: Vision changes, numbness/tingling in extremities, foot wounds 1, 4

Objective

Measure HbA1c at least twice yearly if meeting goals, quarterly if not meeting goals or therapy changed. 1

Essential measurements to document:

  • Blood glucose: Fasting (goal 90-130 mg/dL) and postprandial (goal <180 mg/dL) 1
  • HbA1c: Target <7% for most adults 1
  • Blood pressure: Target <130/80 mmHg 1
  • Lipid panel: LDL goal <100 mg/dL, triglycerides <150 mg/dL, HDL >40 mg/dL 1
  • Renal function: eGFR and urine albumin-to-creatinine ratio 1
  • Weight and BMI: Document for weight loss goals 1
  • Foot examination: Pulses, sensation, skin integrity 1
  • Dilated retinal exam status: Document date of last exam 1

Assessment

Initiate insulin therapy directly if HbA1c ≥9-10% or blood glucose ≥300-350 mg/dL with symptoms. 2

Stratify management based on presentation:

Severe Hyperglycemia (HbA1c ≥10-12% with symptoms or catabolic features)

  • Start basal-bolus insulin regimen immediately 2
  • Total daily dose: 0.3-0.5 units/kg/day (half basal, half bolus) 2

Moderate Hyperglycemia (HbA1c 9-10% or glucose 250-350 mg/dL)

  • Start basal insulin at 10 units daily or 0.1-0.2 units/kg 2
  • Continue metformin for superior glycemic control with reduced insulin requirements 2

Mild to Moderate Hyperglycemia (HbA1c 7-9%)

  • Metformin monotherapy if not already on it 1
  • Add second agent if HbA1c target not met after 3 months at maximum tolerated metformin dose (up to 2000-2550 mg/day) 1, 2

Cardiovascular or Kidney Disease Present

  • Add GLP-1 receptor agonist or SGLT2 inhibitor regardless of HbA1c 4
  • These reduce cardiovascular events by 12-26%, heart failure by 18-25%, and kidney disease progression by 24-39% 4

Plan

Pharmacologic Management

Metformin remains first-line unless contraindicated; start low and titrate up due to GI side effects. 1, 2

Metformin Initiation

  • Start 500 mg once or twice daily with meals 3
  • Increase by 500 mg weekly as tolerated 2
  • Target maximum tolerated dose up to 2000-2550 mg/day 2
  • Continue metformin down to eGFR 30-45 mL/min with dose reduction 1
  • Avoid excessive alcohol intake (potentiates lactic acidosis risk) 3

Second-Line Agent Selection (if HbA1c not at goal after 3 months)

Choose based on patient characteristics 1:

  • Cardiovascular/kidney disease or high CV risk: GLP-1 RA or SGLT2 inhibitor 4
  • Weight loss priority: GLP-1 RA (>5% weight loss) or dual GIP/GLP-1 RA (>10% weight loss) 4
  • Cost-sensitive: Sulfonylurea (but higher hypoglycemia risk) 1
  • Avoid hypoglycemia: DPP-4 inhibitor, GLP-1 RA, or SGLT2 inhibitor 1

Insulin Initiation and Titration

Start basal insulin at 10 units once daily or 0.1-0.2 units/kg body weight. 2

  • Increase by 2 units every 3 days if fasting glucose 140-179 mg/dL 2
  • Goal: fasting glucose 80-130 mg/dL 2
  • Continue metformin when starting insulin 2

Add prandial insulin when basal insulin reaches 0.5-1.0 units/kg/day without achieving HbA1c target. 2

  • Start 4 units rapid-acting insulin before largest meal or 10% of basal dose 2
  • Titrate by 1-2 units or 10-15% every 3 days based on 2-hour postprandial glucose 2

Lifestyle Modifications

Prescribe at least 150 minutes per week of moderate-intensity aerobic activity plus resistance training twice weekly. 1

  • Exercise timing: Afternoon and post-meal exercise may provide better glycemic benefit than morning or pre-meal 5
  • Breaking sedentary time: Short bouts (up to 3 minutes) of light to vigorous movement improve glucose control 5
  • Weight loss goal: At least 5% of body weight for overweight/obese patients 1
  • Diet composition: 40-50% complex carbohydrates, 10-20% protein, monounsaturated fats 6

Monitoring Plan

  • Daily fasting glucose: During insulin titration 2
  • HbA1c: Every 3 months until stable, then every 6 months 1, 2
  • Annual: Comprehensive foot exam, dilated retinal exam, lipid panel, urine albumin-to-creatinine ratio 1

Hypoglycemia Protocol

Treat blood glucose ≤70 mg/dL with 15 grams of rapid-acting carbohydrates. 2

  • Reduce insulin dose by 10-20% when hypoglycemia occurs 2
  • Train patient and family on glucagon administration 1

Diabetes Self-Management Education

Refer to certified diabetes educator at diagnosis and as needed thereafter. 1

  • Insulin injection technique and storage 1
  • Glucose monitoring technique 1
  • Recognition and treatment of hypoglycemia 1
  • Sick day management 1

Common Pitfalls to Avoid

  • Do not use sliding-scale insulin alone in hospitalized patients; use scheduled basal-bolus regimens 2
  • Do not delay insulin in severely hyperglycemic patients (HbA1c ≥9-10%) 2
  • Do not stop metformin when starting insulin unless contraindicated 2
  • Do not ignore cardiovascular risk reduction: Add SGLT2i or GLP-1 RA in high-risk patients regardless of glucose control 4
  • Monitor renal function when using metformin; adjust dose when eGFR 30-45 mL/min, discontinue if <30 mL/min 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Type 2 Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The importance of exercise for glycemic control in type 2 diabetes.

American journal of medicine open, 2023

Research

Type II diabetes mellitus.

Advances in internal medicine, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.